Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

JOHNSON & JOHNSON

(JNJ)
  Report
Delayed Nyse  -  04:00 2022-10-04 pm EDT
165.62 USD   +1.48%
05:09pBankruptcy Judge Pauses New Mexico, Mississippi Lawsuits Over J&J Talc Products
DJ
10/03$500M-plus from opioid deal starts heading to Washington
AQ
10/03Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Johnson & Johnson Ends Global Sales of Cancer-Causing Baby Powder Amid Increased Scrutiny from Consumer Litigation, Science

08/12/2022 | 04:46pm EDT

Courts continue to scrutinize J&J's controversial bankruptcy ploy to avoid liability

MONTGOMERY, Ala., Aug. 12, 2022 /PRNewswire/ -- Legal experts say the decision by Johnson & Johnson (NYSE: JNJ) to halt future sales and distribution of talc-based products worldwide, including its iconic Johnson's Baby Powder, points to mounting pressure on the company to resolve tens of thousands of legal claims brought by ovarian cancer and mesothelioma victims.

Numerous scientific studies spanning decades have established the carcinogenic effects of cosmetic talc, while U.S. and Canadian governmental regulators have called for enhanced testing techniques for products containing the mineral, particularly after independent testing by the U.S. Food & Drug Administration revealed asbestos in consumer samples of talc-based powders. Meanwhile, internal corporate documents presented in trials during the past several years have shown that J&J and its consultants knew of the dangers of the company's products and took steps to deny or otherwise cover up those findings to avoid legal liability.

"J&J has finally done the right thing. Throughout decades of selling talc-based products, the company knew talc could cause deadly cancers to unsuspecting women and men around the world," says Leigh O'Dell of the Beasley Allen Law Firm in Montgomery. "They stopped sales in North America more than two years ago and blamed that move on the litigation. The delay in taking this step is inexcusable. I can only hope J&J will now do the next right: take responsibility and adequately compensate the victims they have needlessly harmed."

The vast majority of the more than 38,000 cases filed by ovarian cancer victims against J&J were consolidated in multidistrict litigation in New Jersey federal court, and bellwether trials had been scheduled to begin last spring. Those proceedings were put on hold in late 2021 when the company chose to pursue a controversial "Texas Two-Step" bankruptcy.

That scheme involved creating a new corporate shell company to hold all talc-related liabilities before taking that entity into bankruptcy. If successful, the tactic would allow Johnson & Johnson to avoid paying cancer victims and protect a market capitalization of approximately a half-trillion dollars. Because of the bankruptcy, all trials in the MDL and others filed in state courts are currently suspended.   

The two-step move has raised eyebrows in Congress, where representatives have begun discussing potential changes to the bankruptcy laws that would prevent this sort of consumer harm in future cases.

"The potential loss of a jury trial is not a mere by-product of the filing; the sole purpose of the bankruptcy is to remove tort claimants from the tort system and strip them of their rights against extraordinarily wealthy and highly solvent entities," wrote Erwin Chemerinsky, Dean of the University of California's Berkeley School of Law, in a brief filed with the bankruptcy court.

"The Debtor is a newly created shell, with no business to restructure, no operations to rehabilitate, and no customers or genuine employees to serve. In short, the Debtor has no reorganizational purpose," he noted in the brief, one of many filed by constitutional scholars raising concerns about the "Two-Step."

The propriety of the bankruptcy and accompanying halt to litigation imposed by the bankruptcy court will be reviewed by the U.S. Court of Appeals for the Third Circuit in a hearing Sept. 19.

About Beasley Allen Law Firm

Headquartered in Montgomery, Ala., Beasley Allen is comprised of more than 70 attorneys and 200 support staff. One of the largest Plaintiffs law firms in the country, Beasley Allen is a national leader in civil litigation, with verdicts and settlements in excess of $26 billion. Beasley Allen was one of only 12 firms in the nation named by Law360 to its Most Feared Plaintiffs Firms list in 2015, and the firm was included on the National Law Journal Midsize Law Firm Hot List and the NLJ Elite Trial Lawyers List in 2014. For more information about our firm, please visit our website at www.beasleyallen.com.

Media Contact:

Barry Pound
800-559-4534  
Barry@androvett.com

Cision
View original content:https://www.prnewswire.com/news-releases/johnson--johnson-ends-global-sales-of-cancer-causing-baby-powder-amid-increased-scrutiny-from-consumer-litigation-science-301605252.html

SOURCE Beasley Allen Law Firm


© PRNewswire 2022
All news about JOHNSON & JOHNSON
05:09pBankruptcy Judge Pauses New Mexico, Mississippi Lawsuits Over J&J Talc Products
DJ
10/03$500M-plus from opioid deal starts heading to Washington
AQ
10/03Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference
BU
10/03UBS Adjusts Johnson & Johnson Price Target to $175 From $180, Maintains Neutral Rating
MT
10/03Janssen Announces Late-Breaking Data from Two Gene Therapy Programs at the American Aca..
AQ
09/28Trending : Johnson & Johnson's New Band-Aid, Tylenol Company to Be Named Kenvue
DJ
09/28Johnson & Johnson : Vision Introduces All Purpose EDOF, TECNIS Symfony OptiBlue IOL, the L..
PU
09/28Johnson & Johnson Says Planned Consumer Health Company to Be Named Kenvue
MT
09/28Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company
BU
09/28Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company
CI
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations